The Current State of the Vascular Low-Frequency Disease Consortium

Outcomes and management are traditionally best studied through prospective randomized trials or national registries when applicable; however, when clinicians encounter patients with rare vascular pathologies they are often left relying on small-series or case reports in determining the best care. Such vascular anomalies do not go unreported, but due to their rarity it can be difficult for surgeons to conclude what treatment modality provides the least risk and/or best outcomes. To target the shortcoming of contemporary, evidenced-based treatment guidelines, the Vascular Low-Frequency Disease Consortium (VLFDC) was created to examine the management and outcomes of low-frequency vascular diseases using a multi-institutional, standardized, database involving institutions around the United States and globally.
Source: Annals of Vascular Surgery - Category: Surgery Authors: Tags: Abstracts accepted for presentation during the Florida Vascular Society ’s 29th Annual Scientific Sessions Meeting Source Type: research